The Biotinidase Enzyme Activity Test is a vital diagnostic screening used primarily in newborns to measure the function of the biotinidase enzyme. This critical enzyme recycles biotin, vitamin B7, which is essential for normal metabolic processes.
The test identifies biotinidase deficiency, an inherited metabolic disorder. Without early detection and treatment, this condition can cause severe neurological damage, seizures, skin rashes, hearing loss, and developmental delays.
Conducted via a routine dried blood spot sample, the test enables prompt clinical intervention with daily biotin supplementation, effectively preventing all symptoms while ensuring healthy lifelong development and bright futures for affected children everywhere today.